Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Brivaracetam vs Lorazepam for Acute Seizures in EMU
NCT03021018Phase 2Completed
- Sponsor
- UCB
- Start
- Feb 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brivaracetam in epilepsy, sponsored by UCB. Started Feb 2017; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03021018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021018.